Beth Israel Deaconess Medical Center
Clinical trials sponsored by Beth Israel Deaconess Medical Center, explained in plain language.
-
Cancer vaccine aims to prevent leukemia relapse in older adults
⭐️ VACCINE ⭐️ OngoingThis study tests a personalized vaccine made from a patient's own leukemia cells and immune cells. The goal is to see if the vaccine can help prevent the cancer from coming back after chemotherapy. It is for adults aged 55 and older with acute myeloid leukemia (AML) who are in re…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 12, 2026 12:08 UTC
-
Immune drug nivolumab takes on returning prostate cancer
Disease control OngoingThis phase 2 study tests nivolumab (Opdivo) in 29 men with high-risk prostate cancer that has returned after initial treatment, shown by rising PSA levels. The drug works by helping the immune system recognize and attack cancer cells. The main goal is to see if nivolumab can cont…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 23, 2026 19:34 UTC
-
Brain scans reveal how Weight-Loss drug targets appetite
Disease control OngoingThis study uses brain scans (fMRI) to see how the weight-loss drug lorcaserin changes activity in brain areas that control appetite and food intake. Forty obese adults will receive either lorcaserin or a placebo pill. Researchers will also measure changes in body composition. The…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 23, 2026 12:08 UTC
-
DASH diet delivered to your door: a new way to fight high blood pressure?
Disease control OngoingThis study tests whether providing home-delivered DASH diet groceries, with help from a dietitian, can lower blood pressure in Black adults who already take medication for hypertension. Participants live in Boston-area neighborhoods with limited access to healthy food. The trial …
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 22, 2026 12:01 UTC
-
Higher dose of breast cancer drug shows promise in early trial
Disease control OngoingThis phase II trial is testing a higher dose (500 mg) of the drug fulvestrant (Faslodex) as a first hormonal treatment for postmenopausal women with hormone receptor positive metastatic breast cancer. The study aims to see if this higher dose improves clinical benefit compared to…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 22, 2026 11:56 UTC
-
Which opioid is best for ventilated ICU patients? new trial aims to find out
Disease control OngoingThis study compares fentanyl and hydromorphone (Dilaudid) for sedating patients on mechanical ventilators in the ICU. About 300 adults will be randomly assigned to one of the two drugs. The main goal is to see if one leads to lower total opioid use. The results could help guide s…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
Smart dosing for IBD: Computer-Guided drug delivery shows promise
Disease control OngoingThis study tests whether using a computer dashboard to guide infliximab dosing is more effective and safer than standard dosing for people with Crohn's disease or ulcerative colitis. About 124 participants will receive either dashboard-guided or standard treatment, with the goal …
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 18, 2026 11:51 UTC
-
New vaccine trial aims to train immune system against leukemia after transplant
Disease control OngoingThis early-phase study tests a custom-made cancer vaccine (DC/AML fusion vaccine) for people with acute myeloid leukemia (AML) who have recently had a stem cell transplant. The vaccine is designed to teach the body's immune cells to recognize and attack remaining leukemia cells. …
Phase: PHASE1 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 15, 2026 19:06 UTC
-
New hope for Hard-to-Treat breast cancers: targeted drug shows promise
Disease control OngoingThis study tests a drug called olaparib in people with metastatic breast cancer that has spread beyond the breast. Participants must have a specific gene change in their tumor that may make it sensitive to this drug. The goal is to see if olaparib can shrink tumors or slow cancer…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Jun 03, 2026 12:05 UTC
-
New tech aims to take the guesswork out of muscle pain diagnosis
Diagnosis OngoingThis observational study tests three non-invasive technologies—ultrasound, electrical impedance, and nerve excitability tests—to see if they can reliably diagnose myofascial pain syndrome. Researchers will compare results from 90 people with and without the condition. The goal is…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 23, 2026 11:56 UTC
-
AI model aims to spot pancreatic cancer risk years in advance
Diagnosis OngoingThis study is testing a computer model called PRISM that uses electronic health records to predict who might develop pancreatic cancer. Researchers will analyze data from over 6 million people aged 40 and older across 44 US healthcare centers. The goal is to see if the model can …
Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 22, 2026 11:58 UTC
-
New study could transform cervical cancer screening for women in botswana
Diagnosis OngoingThis study looks at how well a two-step cervical cancer screening process works in Botswana. It uses an HPV test first, followed by a visual exam, to find early signs of cancer. About 3,000 women aged 25 and older, including those living with HIV, will take part. The goal is to f…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Diagnosis
Last updated Jun 15, 2026 19:03 UTC
-
New HIV prevention shots could protect breastfeeding moms and their babies
Prevention OngoingThis study looks at whether long-acting HIV prevention shots (CAB-LA) are safe and work well for breastfeeding mothers after childbirth. About 500 new mothers in Botswana will get the shots and be followed for 24 months along with their babies. The goal is to see if this method c…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Prevention
Last updated Jun 15, 2026 19:05 UTC
-
Could a pill ease long COVID fatigue? new trial hopes to find out
Symptom relief OngoingThis phase 2a trial tests whether the drug abrocitinib can reduce severe fatigue in adults with Long COVID. About 46 people who were never hospitalized for COVID but now have long-term fatigue will take either 50 mg, 100 mg of abrocitinib, or a placebo daily for 12 weeks. Researc…
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 23, 2026 11:55 UTC
-
New ICU checklist aims to make final moments more comfortable
Symptom relief OngoingThis study tests a simple checklist called CMOT (Comfort Measures Only Time Out) for ICU teams. The goal is to reduce distress in patients when breathing machines are removed at the end of life. Researchers will enroll 184 patients and their care teams across four ICUs to see if …
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 22, 2026 11:58 UTC
-
Can a quick brain zap ease schizophrenia symptoms?
Symptom relief TerminatedThis study tests whether an accelerated schedule of transcranial magnetic stimulation (TMS) is safe and effective for treating symptoms of psychotic disorders like schizophrenia. About 20 adults aged 18-65 with schizophrenia, schizoaffective disorder, or at high risk for psychosi…
Phase: PHASE1, PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 18, 2026 11:48 UTC
-
Tai chi and tech team up to get heart patients moving
Symptom relief OngoingThis study looks at whether tai chi exercises and wearable fitness trackers can help people who have survived a heart attack (acute coronary syndrome) become more physically active. About 70 adults who are currently inactive will take part. The goal is to see if this approach is …
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 17, 2026 12:10 UTC
-
Brain scans reveal how Weight-Loss drug curbs cravings
Symptom relief OngoingThis study looks at how the weight-loss drug Saxenda (liraglutide) changes brain activity related to appetite and food cravings. About 28 obese adults will have brain scans before and after treatment to see how the drug affects hunger-control centers. The goal is to better unders…
Phase: PHASE4 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Symptom relief
Last updated Jun 15, 2026 19:06 UTC
-
Back pain breakthrough? biofeedback training aims to fix walking in seniors
Knowledge-focused TerminatedThis study aimed to see if a four-session biofeedback training program could improve trunk control and walking patterns in older adults with and without chronic low back pain. Researchers planned to compare 20 older adults with back pain to 20 healthy volunteers. However, the stu…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 23, 2026 19:35 UTC
-
Which reversal drug causes fewer bathroom problems after surgery?
Knowledge-focused OngoingThis study reviewed records of 70,000 adults who had non-urinary surgery under general anesthesia. It compared two drugs used to reverse muscle relaxants: sugammadex and neostigmine (given with atropine or glycopyrrolate). The goal was to see which drug is linked to fewer cases o…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 23, 2026 19:34 UTC
-
Scientists hunt for genes behind kidney disease
Knowledge-focused OngoingThis study aims to find the genetic causes of kidney diseases like FSGS and nephrotic syndrome. Researchers will collect saliva and urine samples from up to 2,050 participants, including patients and their family members, as well as healthy volunteers. The goal is to understand w…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 23, 2026 19:34 UTC
-
Tiny study aims to Fine-Tune breathing machines for ECMO patients
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at how well air and blood mix in the lungs of 10 adults on a heart-lung bypass machine called VA ECMO. Researchers will adjust the ventilator pressure and use special monitors to see if they can improve oxygen levels. The goal is to learn more about lung function…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 23, 2026 11:56 UTC
-
Hormone pills may light up hidden prostate cancer on scans
Knowledge-focused OngoingThis study looks at whether a short course of hormone therapy can make prostate cancer cells more visible on PSMA PET scans in men whose cancer has returned after initial treatment. About 9 participants will take standard hormone pills for 4 weeks and then get a scan to see if ne…
Phase: EARLY_PHASE1 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 22, 2026 12:07 UTC
-
Gentler breathing during robot surgery may prevent lung problems
Knowledge-focused ENROLLING_BY_INVITATIONThis pilot study tests whether a gentler, low-intensity breathing support method during robotic surgery can reduce lung collapse and breathing complications after surgery. About 60 adults having robot-assisted abdominal or pelvic surgery will be randomly assigned to either the ne…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:48 UTC
-
Heart valve mystery: scientists hunt for genetic clues in 1,000 patients
Knowledge-focused OngoingThis study collects tissue samples from 1,000 people having heart valve surgery to find genetic causes of calcific aortic valve disease. Researchers will compare normal and diseased tissue to understand why the disease develops. Participants must be at least 20 years old and have…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 18, 2026 11:47 UTC
-
New bone test could spot fracture risk better than standard scans
Knowledge-focused OngoingThis study looks at whether a new, less invasive way to measure bone tissue properties can better identify women at risk for hip and wrist fractures. Researchers will compare these measurements to standard bone density tests. The goal is to improve fracture risk assessment beyond…
Phase: NA • Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:51 UTC
-
500 seniors with heart devices tracked to improve care and decisions
Knowledge-focused ENROLLING_BY_INVITATIONThis study follows 500 adults over age 65 who are getting a new implantable defibrillator (ICD) for the first time. Researchers will track their health, daily function, and quality of life for 18 months, with optional follow-up up to 10 years. The goal is to better understand how…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:04 UTC
-
Can a computer predict liver cancer before it strikes?
Knowledge-focused OngoingThis study checks if a computer model called LIRIC can accurately predict who will develop liver cancer using electronic health records. Researchers will track 6 million adults aged 40 and older without a history of liver cancer to see how well the model works. The goal is to imp…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jun 09, 2026 12:07 UTC